ARC Centre of Excellence for Integrative Brain Function

Total Page:16

File Type:pdf, Size:1020Kb

ARC Centre of Excellence for Integrative Brain Function ARC Centre of Excellence for Integrative Brain Function ARC Centre ANNUAL REPORT ANNUAL REPORT 2017 ANNUAL REPORT ARC CENTRE OF EXCELLENCE 2017FOR INTEGRATIVE BRAIN FUNCTION Cover image: Art Competition Category 2, 3rd place by Gabby, age 7 COLLABORATING, PARTNER AND AFFILIATE ORGANISATIONS Collaborating organisations Partner organisations Affiliate organisations The ARC Centre of Excellence for Integrative Brain Function Annual Report 2017 Contents INTRODUCTION About 4 Vision and Mission 6 Governance 7 Message from the Director 8 Message from the Chair 10 PERSONNEL 12 Centre Staff 16 Collaboration Network 18 RESEARCH REPORT 20 Research Themes 22 Research Projects 24 Publications 30 Presentations 34 CENTRE PROGRAMS 42 Education 44 The Brain Dialogue 48 Neuroethics 52 Neuroinformatics 54 Industry Engagement 56 Gender, Equity and Diversity 57 Centre Events 58 Sponsorship 60 LOOKING AHEAD 2018 62 KEY PERFORMANCE INDICATORS 64 FINANCE AND FUNDING 66 INTRODUCTION About the Centre Understanding how the brain interacts with the world is one of the greatest challenges of the 21st century. To address this challenge, brain researchers from around the country, with expertise across multiple disciplines have joined forces to establish the ARC Centre of Excellence for Integrative Brain Function (Brain Function CoE). The Centre has developed an integrated research program aimed at studying the brain across a multitude of spatial and temporal scales. By integrating research across scales and disciplines, the outcomes of the Centre will provide a more comprehensive understanding of how the brain functions as a whole. The Centre's research has focused on understanding how the brain integrates information at multiple scales, from nerve cell electrical and biochemical activity through patterns of activity in large scale circuit networks to yield complex behaviour in the three key daily-life functions of attention, prediction, and decision behaviour. In parallel, Centre researchers are developing powerful predictive models of processes at each of the different scales to feed into the development of novel neural technologies for patentable devices and software. Beyond research outcomes, the Centre has a commitment to maximise its influence, by disseminating research achievements and fostering discussion of emerging issues with stakeholders, both within academia and across the broader public sphere. In addition, the Centre is fostering a community of scholars by mentoring future research leaders skilled in this multi-disciplinary approach that will meld neuroscience, physics, and engineering. Through this process the Centre strives to maintain topicality and remain at the forefront of international research by engaging with international neuroscience initiatives, to ensure Australian neuroscientists provide an influential voice in the ethical, social and economic impact of brain research to the wider community. Read more about the Centre brainfunction.edu.au Vision and mission Strategic objectives Awarded in 2014 as part of the Australian Research Council 1. Reveal how the brain integrates information in large- (ARC) Centres of Excellence Scheme, the Brain Function scale networks to yield complex behaviour. CoE is a seven-year research program funded by the ARC with contributions from six universities across Australia. 2. Develop neural technologies and translate them into patentable devices and software; Ensure that Led by Monash University (Administering Organisation), Australians benefit from the rapid advances being the Centre brings together researchers from the made in neurotechnologies. University of Queensland, the University of Melbourne, the University of Sydney, Australian National University, 3. Maximise dissemination and exploitation of and the University of New South Wales (Collaborating research findings across the education, medical and Organisations), alongside QIMR Berghofer, and 11 government sectors, into industry, and across the international partnering institutions across Europe, Japan broader community, to facilitate social change and and the USA (Partner Organisations). progress. Mentor a new generation of future leaders at the Vision 4. interfaces between neuroscience, physics, and To understand how the brain interacts with the world. engineering, to create an international competitive culture of combined theoretical and experimental neuroscience. Mission 5. Position Australia amongst the world leaders in the By focusing on the complex brain functions that underlie international drive to expand the understanding attention, prediction and decision-making, Centre for of the brain. Serve as an Australian focal point for Integrative Brain Function researchers are undertaking interactions with leading international neuroscience fundamental investigations into the principles of brain initiatives, including the Human Brain Project and the structure and function. The Centre is studying the BRAIN initiative. relationship between brain activity and behaviour at multiple spatial and temporal scales, to build an integrated model of how attention, prediction and decision- making occurs. This is being accomplished by a research program based on four interconnected themes: Cells and Synapses, Neural Circuits, Brain Systems, and Models and Technologies. Advisory Board Director Research Administration Centre programs EXECUTIVE COMMITTEE Centre manager Neuroinformatics Theme leaders Central theme staff Industry engagement Organisational representatives Node administrators Education & outreach Gender, equity & diversity CENTRE RESEARCHERS Neuroethics Chief investigators (CIs) Partner investigators (PIs) Associate investigators (AIs) Centre fellows (Post-Docs) Centre scholars (PhD students) Affiliate researchers Organisational chart 6 ANNUAL REPORT 2017 - introduction Governance Advisory Board Executive Committee The Advisory Board provides strategic direction and The Executive Committee oversees the Centre’s operations advice regarding all aspects of the Centre’s activities to the and comprises representatives from each research theme, Director. The Board meets a minimum of twice per year – collaborating institution and senior Centre personnel. both in person and virtually, and are invited to partake in In 2017, the Executive Committee met monthly and annual scientific meetings. comprised: Members have significant experience in collaborations involving multiple large organisations, as well as international neuroscience activities, industry, and Executive Committee members government engagement. In 2017, the Advisory Board welcomed the appointment of two additional members, » Prof Gary Egan, Director, Brain Function CoE, Dr Jeanette Pritchard and Dr Stella Clark, who will Monash University provide guidance on industry linkages and mentorship » Prof Marcello Rosa, Deputy Director, Brain Function opportunities for Centre members. CoE, Monash University Advisory Board members » Prof Jason Mattingley, Associate Director, Brain Function CoE, Brain Systems, University of » Prof Lyn Beazley, Chair, Past Chief Scientist of Queensland Western Australia, Perth, Australia » Prof Pankaj Sah, Neural Circuits, University of » Dr Amanda Caples, Lead Scientist, Victorian State Queensland Government, Melbourne, Australia » Prof Greg Stuart, Cells and Synapses, Australian » Prof John Funder, Senior Fellow, Hudson Institute of National University Medical Research, Melbourne, Australia » Prof Peter Robinson, Models and Technologies, » Prof David van Essen, Director, Human Connectome University of Sydney Project, St Louis, USA » Prof Ulf Eysel, Principal Investigator, Department of » Prof Michael Ibbotson, University of Melbourne Neurophysiology, Ruhr University, Bochum, Germany » Prof George Paxinos, University of New South Wales » Dr Allan Jones, CEO, Allen Brain Institute, Seattle, » Dr Glenn Papworth, Centre Manager, Monash USA University » Dr Jeanette Pritchard, Executive Officer, The Garnett Passe and Rodney Williams Memorial Foundation, Melbourne, Australia » Dr Stella Clark, Executive Director, Stella Connect Pty Ltd, Melbourne, Australia Senior leadership Centre Director Prof Gary Egan oversees the Centre’s research and operations while playing a key role in the development of industry engagement activities. Deputy Director, Prof Marcello Rosa, is instrumental in the development of international collaborations and partnerships. Associate Director Prof Jason Mattingley plays a critical role in the strategic development of key initiatives in the Education and Training Program and acts as an alternate for Professor Rosa. ARC CoE FOR INTEGRATIVE BRAIN FUNCTION 7 Message from the Director The essence of a Centre of Excellence “– the whole truly being more“ than the sum of its individual parts – was evident in the Centre in 2017. 8 ANNUAL REPORT 2017 - introduction In 2017 the Centre for Integrative Brain Function passed the halfway mark in our seven-year funding period, and the process of preparing for our successful mid-term review (held in November) necessitated reflection on what we as a Centre of Excellence have achieved to this point and where we plan to go from here. In 2017 we reached the midpoint of the Australian Research programs continued to thrive in 2017, with unprecedented Council’s funding period for the Centre for Integrative turnout from the general public to community Brain Function. During the year we successfully prepared engagement events that were held across the country. We for the mid-term review that was held in November, we also
Recommended publications
  • 3Rd Macquarie Neurodegeneration Meeting 28-29 OCTOBER 2020
    CENTRE FOR MOTOR NEURONEDISEASE RESEARCH Faculty of Medicine, Health and Human Sciences 3rd Macquarie Neurodegeneration Meeting 28-29 OCTOBER 2020 AN EVENT FOR AUSTRALIAN NEUROSCIENTISTS TO SHOWCASE THEIR RESEARCH AND TO STIMULATE CONVERSATION AND FOSTER COLLABORATION TO DEVELOP TREATMENTS FOR DISEASES INCLUDING MOTOR NEURON DISEASE, ALZHEIMER’S DISEASE, FRONTOTEMPORAL DEMENTIA, PARKINSON’S DISEASE AND OTHER DEGENERATIVE BRAIN DISORDERS. Our Sponsor We are incredibly thankful to our sponsor for their support of the Macquarie Neurodegeneration Meeting Gain a new perspective on the nervous system and accelerate discovery. Explore 10x Genomics Solutions for neuroscience in this short video. 2 Our Sponsor 3 Our Sponsor 4 Welcome The Macquarie Neurodegeneration Meeting is an annual event hosted by the Centre for Motor Neuron Disease Research, Macquarie University. The aim of this event is for Australian neuroscientists to showcase their research and to stimulate conversation and foster collaboration to develop treatments for diseases including motor neuron disease, Alzheimer’s disease, frontal temporal dementia, Parkinson’s disease and other degenerative brain disorders. We welcome your involvement and hope the day provides inspiration and assists in fostering collaboration and connections in the neurodegeneration research community. Yours Sincerely, The Conference Organising Committee COMMITTEE MEMBERS Centre for Motor Neuron Disease Research Professor Julie Atkin Co-Director Professor Ian Blair Co-Director Christina Cassidy Centre Administrator
    [Show full text]
  • Wellcome Trust Annual Report and Financial Statements 2017 Contents
    Annual Report and Financial Statements 2017 2 Wellcome Trust Annual Report and Financial Statements 2017 Contents Report from the Chair and the Director 5 Trustee’s Report 8 What we do 8 Review of Charitable Activities 9 Review of Investment Activities 18 Financial Review 29 Structure and Governance 34 Risk Management 37 Remuneration Report 40 Audit Committee Report 43 Independent Auditor’s Report 45 Financial Statements 58 Consolidated Statement of Financial Activities 58 Consolidated Balance Sheet 59 Statement of Financial Activities of the Trust 60 Balance Sheet of the Trust 61 Consolidated Cash Flow Statement 62 Notes to the Financial Statements 63 Reference and Administrative Details 117 3 Wellcome Trust Annual Report and Financial Statements 2017 “ At Wellcome, we believe in the power of ideas to improve health” Jeremy Farrar Director 4 Wellcome Trust Annual Report and Financial Statements 2017 Report from the Chair and the Director “Our core approach is funding people to explore great ideas, at every step of the way from discovery to impact” At Wellcome, we believe in the power of ideas to improve cause of maternal mortality in the world. It also includes health. Funded from our independent investment portfolio, supporting research in the humanities and social sciences, we support thousands of scientists and researchers in more such as a project which this year published ethical guidelines than 70 countries, as well as innovators, educators and artists. for involving pregnant women in Zika vaccine research. Together, we take on big problems, fuel imaginations and spark And resources like the Human Induced Pluripotent Stem Cell debate, working always to achieve better health for everyone.
    [Show full text]
  • The Brain and Mind Centre Optymise Cohort: Tracking Multidimensional Outcomes in Young People Presenting for Mental Healthcare
    Open access Cohort profile BMJ Open: first published as 10.1136/bmjopen-2019-030985 on 29 March 2020. Downloaded from Cohort profile: the Brain and Mind Centre Optymise cohort: tracking multidimensional outcomes in young people presenting for mental healthcare Joanne S Carpenter ,1 Frank Iorfino ,1 Shane Cross ,1,2 Alissa Nichles,1 Natalia Zmicerevska ,1 Jacob J Crouse ,1 Jake R Palmer ,1,3 Alexis E Whitton,1 Django White,1 Sharon L Naismith,1,2,4 Adam J Guastella,1 Daniel F Hermens ,1,5 Jan Scott ,1,6,7 Elizabeth M Scott ,1,8 Ian B Hickie 1 To cite: Carpenter JS, Iorfino F, ABSTRACT Strengths and limitations of this study Cross S, et al. Cohort profile: Purpose The Brain and Mind Centre (BMC) Optymise the Brain and Mind Centre cohort assesses multiple clinical and functional domains ► This cohort tracks longitudinally a large number of Optymise cohort: tracking longitudinally in young people presenting for mental health multidimensional outcomes in young people presenting for mental health care and care and treatment. Longitudinal tracking of this cohort will young people presenting for treatment early in the course of common mental allow investigation of the relationships between multiple mental healthcare. BMJ Open disorders. It will provide detailed information about outcome domains across the course of care. Subsets of 2020;10:e030985. doi:10.1136/ variations in the course of emerging illness over a have completed detailed neuropsychological bmjopen-2019-030985 Optymise prolonged, and developmentally sensitive, follow-up and neurobiological assessments, permitting investigation period. ► Prepublication history and of associations between these measures and longitudinal additional material for this ► Multiple clinical and functional outcome domains course.
    [Show full text]
  • The Wellcome Trust Limited Annual Report and Financial Statements Year Ended 30 September 2016
    The Wellcome Trust Limited Annual Report and Financial Statements Year ended 30 September 2016 Company number 2711000 The Wellcome Trust Limited Contents Page Governors’ Report 2 Independent Auditor’s Report 4 Profit and Loss Account 6 Balance Sheet 7 Notes to the Financial Statements 8 Administrative Details 10 1 Company number 2711000 The Wellcome Trust Limited Governors’ Report For the year ended 30 September 2016 The Governors of The Wellcome Trust Limited (the “Company”) present their report and the audited Financial Statements for the year ended 30 September 2016. This Governors’ report has been prepared in accordance with the provisions applicable to companies entitled to the small companies’ exemption. Principal Activities The activity of the Company is to act as Trustee of the Wellcome Trust, a charity registered in England and Wales (registered charity number 210183) under the Charities Act 2011. The Directors, known as Governors, are officers of the Company. The Company is limited by guarantee and has no share capital. As at 30 September 2016, there were 10 members (2015: 11), all of whom are Governors. Every member of the Company undertakes to contribute such amount as may be required (not exceeding one pound) to the assets of the Company. Results for the year The Company charges management fees to the Wellcome Trust sufficient to recover Governors' emoluments and other expenses incurred in carrying out its role as Trustee, such that the Company made neither a profit nor a loss in the current year. The Company will continue to operate in this manner in the coming year. Political and Charitable Donations The Company made no political or charitable donations during the year (2015: nil).
    [Show full text]
  • Research Excellence
    Research excellence We are one of the world’s top research universities and a member of Australia’s prestigious Group of Eight network and the Association of Pacific Rim Universities. We also partner with others that excel in research, including Harvard, Stanford, Utrecht University, Tsinghua University and the University of Hong Kong. sydney.edu.au/research Our research is driven by the big such as health, climate change and − the Australian Institute for picture and we provide a hub for food security. Our multidisciplinary Nanoscale Science and industry, government and community research centres include: Technology that is transforming groups to collaborate with us and Sydney into a global hub for connect with our researchers and − the Charles Perkins Centre discovering and harnessing new students. The development of major dedicated to easing the global science at the nanoscale. innovations such as the black box burden of obesity, diabetes, recorder, pacemaker, Wifi and the cardiovascular disease We invest in research that changes bionic ear started here. and related conditions the way we think about the world. − the Brain and Mind Centre, a Find out more about our research: We are also home to 90 world- leader in research, education sydney.edu.au/research renowned multidisciplinary research and treatment of a range and teaching centres that are of diseases from autism to strongly positioned to tackle some schizophrenia, depression, of the world’s biggest challenges, dementia and Parkinson’s disease In the top 50 All our research We are tripling of the world’s best is ranked at world our investment in CRICOS 00026A CRICOS research universities standard or above research (QS World University (Excellence in Research for (University of Sydney Rankings 2018) Australia report, 2015) Strategic Plan, 2016-20 ) – POSTGRADUATE RESEARCH HOW TO APPLY HOW TO APPLY RESEARCH These steps will guide you in applying for a research – master's or PhD degree at the University of Sydney.
    [Show full text]
  • BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available
    BMJ Open: first published as 10.1136/bmjopen-2020-046830 on 7 July 2021. Downloaded from BMJ Open is committed to open peer review. As part of this commitment we make the peer review history of every article we publish publicly available. When an article is published we post the peer reviewers’ comments and the authors’ responses online. We also post the versions of the paper that were used during peer review. These are the versions that the peer review comments apply to. The versions of the paper that follow are the versions that were submitted during the peer review process. They are not the versions of record or the final published versions. They should not be cited or distributed as the published version of this manuscript. BMJ Open is an open access journal and the full, final, typeset and author-corrected version of record of the manuscript is available on our site with no access controls, subscription charges or pay-per-view fees (http://bmjopen.bmj.com). If you have any questions on BMJ Open’s open peer review process please email [email protected] http://bmjopen.bmj.com/ on September 27, 2021 by guest. Protected copyright. BMJ Open BMJ Open: first published as 10.1136/bmjopen-2020-046830 on 7 July 2021. Downloaded from Repetitive transcranial magnetic stimulation (rTMS) in autism spectrum disorder: protocol for a multicentre randomised controlled clinical trial ForJournal: peerBMJ Open review only Manuscript ID bmjopen-2020-046830 Article Type: Protocol Date Submitted by the 11-Nov-2020 Author: Complete List of Authors: Enticott,
    [Show full text]
  • Registered Company No: 2711000
    The Wellcome Trust Limited Annual Report and Financial Statements Year ended 30 September 2015 Company number 2711000 The Wellcome Trust Limited Contents Page Governors’ Report 2 Independent Auditors’ Report 4 Profit and Loss Account 6 Balance Sheet 7 Notes to the Financial Statements 8 Administrative Details 10 1 Company number 2711000 The Wellcome Trust Limited Governors’ Report For the year ended 30 September 2015 The Governors of The Wellcome Trust Limited (the “Company”) present their report and the audited Financial Statements for the year ended 30 September 2015. Principal Activities The activity of the Company is to act as Trustee of the Wellcome Trust, a charity registered in England and Wales (registered charity number 210183) under the UK Charities Act 2011. The Directors, known as Governors, are the only employees of the Company. The Company is limited by guarantee and has no share capital. As at 30 September 2015, there were 11 members (2014: 11), all of whom are Governors. Every member of the Company undertakes to contribute such amount as may be required (not exceeding one pound) to the assets of the Company. Results for the year The Company charges management fees to the Wellcome Trust sufficient to recover Governors' emoluments and other expenses incurred in carrying out its role as Trustee, such that the Company made neither a profit or a loss in the current year. The Company will continue to operate in this manner in the coming year. Political and Charitable Donations The Company made no political or charitable donations during the year (2014: nil). Internal Control and Risk Management The Company is not exposed to any major risks.
    [Show full text]
  • Measuring Social Anxiety in Adults with Autism Spectrum Disorder: Psychometric
    Running head: PSYCHOMETRIC PROPERTIES OF SOCIAL ANXIETY MEASURES IN ASD Measuring Social Anxiety in Adults with Autism Spectrum Disorder: Psychometric Properties of Self-Report Instruments Authors: Kelsie A. Boulton1,2, & Adam J. Guastella1,2 1. Autism Clinic for Translational Research, Brain and Mind Centre, Children’s Hospital Westmead Clinical School, Faculty of Medicine and Health, University of Sydney, Camperdown, New South Wales, 2050, Australia. 2. Child Neurodevelopment and Mental Health Team, Brain and Mind Centre, Children’s Hospital Westmead Clinical School, Faculty of Medicine and Health, University of Sydney, Camperdown, New South Wales, 2050, Australia. Please address correspondence to: Prof Adam Guastella Brain & Mind Centre The University of Sydney 100 Mallett Street Camperdown, NSW 2050 Australia [email protected] PSYCHOMETRIC PROPERTIES OF SOCIAL ANXIETY MEASURES IN ASD 2 Abstract Adults with autism spectrum disorder (ASD) are at elevated risk for social anxiety disorder (SAD). Limited information exists on the appropriateness of using social anxiety instruments with these adults. This study examines psychometric properties of self-report social anxiety instruments in autistic adults without intellectual disability, compared to adults with SAD. Additionally, we compared instrument scores between autistic adults with a dual diagnosis of SAD and adults with SAD only. Adults diagnosed with SAD (N=316) or ASD (N=102) were recruited from the Brain and Mind Centre in New South Wales, Australia. Sixty autistic participants received a diagnosis of SAD. Participants completed the Liebowitz Social Anxiety Scale-self-report, the Social Interaction Anxiety Scale, the Social Phobia Scale, and the Brief Fear of Negative Evaluation Scale. All instruments showed excellent internal consistency in autistic adults.
    [Show full text]
  • Brain and Mind Centre Annual Report
    Our sydney.edu.au Brain and Mind Centre Annual Report 2015-16 patients’ success sydney.edu.au/brain-mind sydney.edu.au/brain-mind 0774 2 9351 +61 The University of Sydney Contact us is our greatest reward. Forest Stewardship Council (FSC®) is a globally recognised certification Forest Stewardship Council (FSC®) is a globally recognised certification overseeing all fibre sourcing standards. This provides guarantees for the consumer that products are made of woodchips from well-managed forests and other controlled sources with strict environmental, economical and social standards. Contents Welcome ............................................ 2 Co-Directors...........................................2 Message from Vice Chancellors ...............3 - Overview ............................................ 4 Teams and key research themes ..............4 Partnerships ...........................................6 - Child Development and Behaviour ......... 8 Our core business ...................................9 Highlights .............................................. 10 Key projects and clinical trials ............... 12 2017 and beyond ................................... 13 Key publications .................................... 14 - Youth Mental Health ............................ 18 Our core business ................................. 18 Brain and Mind Centre Annual Report 2015-16 Highlights ..............................................20 2017 and beyond ...................................22 Key projects and clinical trials ..............23 Key
    [Show full text]
  • The University of Sydney Health and Wellness
    The University of Sydney Health and Wellness Presented by Dr Sarah Robbins Faculty of Medicine and Health Institute of Bone and Joint research The University of Sydney Page 1 Why collaborate with The University of Sydney? Established in 1850, we are Australia’s first university. – Today we are ranked in the world’s top 50 universities. – More than 20 of our subjects are ranked in the world’s top 30. – Our research in every area is ranked as performing at world standard or above. Last year we received more than $350 million in government funding for research. – We currently have 60,000 students including nearly 26,000 international students from more than 130 countries. The University of Sydney Page 2 – 320,000+ alumni in more than 170 countries. Who do we currently collaborate with? The University of Sydney Page 3 What are we doing about? – We are tripling our research investment to $150 million per year by 2020 to enable our academic staf to improve the lives of people in Australia and around the world. – Since 2011 we have invested more than $1.7 billion in exceptional facilities, and we are home to a cluster of research centres that supports multidisciplinary, collaborative projects. – By 2020, we aim to give 50 percent of our students the opportunity to study overseas during their degree. The University of Sydney Page 4 Our world-class research centres – The Charles Perkins Centre is dedicated to easing the global burden of obesity, diabetes and cardiovascular disease. – Sydney Nano is transforming our city into a global hub for discovering and harnessing new science at the nanoscale.
    [Show full text]
  • Brain Communications Ain Communications
    doi:10.1093/braincomms/fcaa235 BRAIN COMMUNICATIONS 2021: Page 1 of 8 | 1 BRAINAIN COMMUNICATIONSCOMMUNICATIONS Cerebrospinal fluid liquid biopsy for detecting Downloaded from https://academic.oup.com/braincomms/article/3/1/fcaa235/6105078 by University of Melbourne user on 26 March 2021 somatic mosaicism in brain Zimeng Ye,1 Zac Chatterton,2 Jahnvi Pflueger,3,4 John A. Damiano,1 Lara McQuillan,1 Anthony Simon Harvey,5,6,7 Stephen Malone,8 Hongdo Do,9,10,11 Wirginia Maixner,12 Amy Schneider,1 Bernadette Nolan,8 Martin Wood,13 Wei Shern Lee,5,6 Greta Gillies,5,6 Kate Pope,5 Michael Wilson,5,6 Paul J. Lockhart,5,6 Alexander Dobrovic,10,11,14,* Ingrid E. Scheffer,1,5,6,7 Melanie Bahlo,15,16 Richard J. Leventer,5,6,7 Ryan Lister,3,4 Samuel F. Berkovic,1,† and Michael S. Hildebrand1,5,† * Present address: Department of Medicine (Austin Health), Translational Genomics and Epigenomics Laboratory, University of Melbourne, Melbourne, Victoria 3084, Australia † These authors contributed equally to this work. Brain somatic mutations are an increasingly recognized cause of epilepsy, brain malformations and autism spectrum disorders and may be a hidden cause of other neurodevelopmental and neurodegenerative disorders. At present, brain mosaicism can be detected only in the rare situations of autopsy or brain biopsy. Liquid biopsy using cell-free DNA derived from cerebrospinal fluid has detected somatic mutations in malignant brain tumours. Here, we asked if cerebrospinal fluid liquid biopsy can be used to detect somatic mosaicism in non-malignant brain diseases. First, we reliably quantified cerebrospinal fluid cell-free DNA in 28 patients with focal epilepsy and 28 controls using droplet digital PCR.
    [Show full text]
  • Witness Statement of Professor David Leon Copolov Ao
    WIT.0001.0184.0001 Royal Commission into Victoria's Mental Health System WITNESS STATEMENT OF PROFESSOR DAVID LEON COPOLOV AO I, David Leon Copolov, Professor of Psychiatry, Monash University and Pro-Vice-Chancellor, Major Campuses and Student Engagement, of Monash University, Wellington Road, Clayton, Victoria 3800, say as follows: I make this statement in my private professional capacity as a psychiatrist, academic and former researcher, the long-standing Executive Director of the Mental Health Research Institute of Victoria (from 1985-2004) and my previous governance experience as a Director of the Board of the Royal Women’s Hospital (my term having ended on 30 June 2020) and on the Board of the Peter MacCallum Cancer Centre, with six years (2007- 2013) as Deputy Chairman of that Board and five years (2005-2010) as Chair of the Research Committee of that Board. My experience, since 2009, in Senior Management at Monash University, Australia’s largest university, has also guided my views and recommendations about ‘big system’ reform in the area of mental health. My opinions are not to be interpreted as being provided on behalf of Monash University, the University of Melbourne or any other institution or organisation that I am or have been associated with. 2 As detailed below, I do not have experience on the frontline of the public mental health system. However, I have had extensive peer contact with colleagues in the public mental health system, and am an ardent (but unappointed) advocate for those who are served by and who work in that system. I am also an aggregator of information from people associated with and documentary sources relating to the Victorian public mental health sector.
    [Show full text]